Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

40.58USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$40.58
Open
--
Day's High
--
Day's Low
--
Volume
25
Avg. Vol
2,836,937
52-wk High
$44.53
52-wk Low
$37.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.83 December 25 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 4 10,441.90 10,923.60 10,159.80 9,119.47
Quarter Ending Dec-17 4 10,087.60 10,669.10 9,795.92 9,033.31
Year Ending Dec-17 5 39,987.60 41,289.90 39,086.60 37,839.30
Year Ending Dec-18 5 40,758.50 42,421.80 39,164.30 39,104.70
Earnings (per share)
Quarter Ending Sep-17 1 0.83 0.83 0.83 --
Quarter Ending Dec-17 1 0.74 0.74 0.74 --
Year Ending Dec-17 4 2.87 2.94 2.80 2.77
Year Ending Dec-18 5 2.87 2.93 2.79 3.07
LT Growth Rate (%) 1 11.50 11.50 11.50 10.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 9,527.30 9,365.71 161.58 1.70
Quarter Ending Mar-17 9,399.24 9,230.00 169.24 1.80
Quarter Ending Dec-16 9,310.90 9,414.23 103.32 1.11
Quarter Ending Sep-16 9,184.95 9,928.91 743.96 8.10
Quarter Ending Jun-16 8,366.71 9,210.12 843.41 10.08
Earnings (per share)
Quarter Ending Jun-17 0.69 0.70 0.01 2.19
Quarter Ending Mar-17 0.63 0.63 0.00 0.00
Quarter Ending Dec-16 0.64 0.65 0.01 1.56
Quarter Ending Sep-16 0.74 0.85 0.11 14.86
Quarter Ending Jun-16 0.55 0.69 0.14 25.45

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 10,441.90 10,441.90 10,338.80 10,397.40 9,119.47
Quarter Ending Dec-17 10,087.60 10,087.60 10,002.00 10,203.10 9,033.31
Year Ending Dec-17 39,987.60 39,987.60 39,679.30 39,745.50 37,839.30
Year Ending Dec-18 40,758.50 40,758.50 40,662.80 40,967.70 39,104.70
Earnings (per share)
Quarter Ending Sep-17 0.83 0.83 0.81 0.83 --
Quarter Ending Dec-17 0.74 0.74 0.72 0.75 --
Year Ending Dec-17 2.87 2.87 2.84 2.86 2.77
Year Ending Dec-18 2.87 2.87 2.85 2.89 3.07

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 2 1
Quarter Ending Dec-17 0 0 2 1
Year Ending Dec-17 0 0 2 1
Year Ending Dec-18 0 0 2 1
Earnings
Quarter Ending Sep-17 0 0 1 0
Quarter Ending Dec-17 0 0 1 0
Year Ending Dec-17 0 0 2 0
Year Ending Dec-18 0 0 2 0